Anti-allodynic effects of intrathecally and intracerebroventricularly administered 26RFa, an intrinsic agonist for GRP103, in the rat partial sciatic nerve ligation model

Peptides

Volumn 32, Issue 6, 2011, Pages 1262-1269

  Yamamoto, Tatsuo ^a   Miyazaki, Rika ^a   Yamada, Toshihiko ^a   Shinozaki, Tomonari ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Dorsal root ganglion; GPR103; Immunohistochemistry; Neuropathic pain

Indexed keywords

26RFA; ANTINOCICEPTIVE AGENT; CARRIER PROTEINS AND BINDING PROTEINS; GLUCOSE REGULATED PROTEIN 103; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE FF; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; AREA UNDER THE CURVE; ARTICLE; ATTENUATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOTOR PERFORMANCE; NERVE CELL; NERVE INJURY; NERVE LIGATION; NEUROPATHIC PAIN; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SPINAL GANGLION;

ANIMALS; ANTIBODIES; CATHETERIZATION; CEREBRAL VENTRICLES; DOSE-RESPONSE RELATIONSHIP, DRUG; GANGLIA, SPINAL; HYPERALGESIA; INJECTIONS, SPINAL; LIGATION; MALE; MEMBRANE GLYCOPROTEINS; MICROINJECTIONS; MOTOR ACTIVITY; NEURALGIA; NEUROPEPTIDES; PAIN MEASUREMENT; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE; SCIATIC NERVE;

RATTUS;

EID: 79958010799     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2011.03.008     Document Type: Article

References (27)

1. F. Bruzzone, B. Lectez, D. Alexandre, S. Jegou, L. Mounien, and H. Tollemer Distribution of 26RFa binding sites and GPR103 mRNA in the central nervous system of the rat J Comp Neurol 503 2007 573 591 (Pubitemid 47051368)
2. F. Bruzzone, B. Lectez, H. Tollemer, J. Leprince, C. Dujardin, and W. Rachidi Anatomical distribution and biochemical characterization of the novel RFamide peptide 26RFa in the human hypothalamus and spinal cord J Neurochem 99 2006 616 627 (Pubitemid 44477216)
3. S.R. Chaplan, F.W. Bach, J.W. Pogrel, J.M. Chung, and T.L. Yaksh Quantitative assessment of tactile allodynia in the rat paw J Neurosci Methods 53 1994 55 63 (Pubitemid 24238751)
4. N. Chartrel, C. Dujardin, Y. Anouar, J. Leprince, A. Decker, and S. Clerens Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity Proc Natl Acad Sci USA 100 2003 15247 15252 (Pubitemid 37518047)
5. M. Costigan, K. Befort, L. Karchewski, R.S. Griffin, D. D'Urso, and A. Allchorne Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury BMC Neurosci 3 2002 16
6. W.J. Dixon Efficient analysis of experimental observations Annu Rev Pharmacol Toxicol 20 1980 441 462
7. Q. Fang, J. Guo, F. He, Y.-I. Peng, M. Chang, and R. Wang In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist Peptide 27 2006 2207 2213 (Pubitemid 44189628)
8. Q. Fang, Q. Liu, N. Li, T.N. Jiang, Y.L. Li, and X. Yan Cardiovascular effects of intravenous administered 26RFa, a novel RFamide peptide ligand for GPR103, in anaesthetised rats Eur J Pharmacol 621 2009 61 66
9. S. Fukusumi, H. Yoshida, R. Fujii, M. Maruyama, H. Komatsu, and Y. Habata A new peptidic ligand and its receptor regulating adrenal function in rats J Biol Chem 278 2003 46387 46395 (Pubitemid 37452209)
10. T. Hökfelt, X. Zhang, X. Xu, and Z. Wiesenfeld-Hallin Central consequences of peripheral nerve damage S.B. McMahon, M. Koltzenburg, Wall and Melzack's textbook of pain 5th ed. 2006 Elsevier Philadelphia 947 959
11. R.R. Ji, and C.J. Woolf Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain Neurobiol Dis 8 2001 1 10 (Pubitemid 32171813)
12. J. Kampe, P. Wiedmer, P.T. Pfluger, T.R. Castaneda, L. Burget, and H. Mondala Effect of central administration of QRFP(26) peptide on energy balance and characterization of a second QRFP receptor in rat Brain Res 1119 2006 133 149 (Pubitemid 44647238)
13. C. Mollereau, H. Mazarguil, D. Marcus, I. Quelven, M. Kotani, and V. Lannoy Pharmacological characterization of human NPFF1 and NPFF2 receptors expressed in CHO cells by using NPY Y1 receptor antagonists Eur J Pharmacol 451 2002 245 256 (Pubitemid 35254027)
14. R. Moriya, H. Sano, T. Umeda, M. Ito, Y. Takahashi, and M. Matsuda RFamide peptide QRFP43 causes obesity with hyperphagia and reduced thermogenesis in mice Endocrinology 147 2006 2916 2922 (Pubitemid 43764627)
15. S.D. Primeaux, C. Blackmon, M.J. Barnes, H.D. Braymer, and G.A. Bray Central administration of the RFamide peptides, QRFP-26 and QRFP-43, increases high fat food intake in rats Peptides 29 2008 1994 2000
16. K. Rudolf, W. Eberlein, W. Engel, H.A. Wieland, K.D. Willim, and M. Entzeroth The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226 Eur J Pharmacol 271 1994 R11 13
17. Z. Seltzer, R. Dubner, and Y. Shir A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury Pain 43 1990 205 218 (Pubitemid 20385185)
18. S. Takayasu, T. Sakurai, S. Iwasaki, H. Teranishi, A. Yamanaka, and S.C. Williams A neuropeptide ligand of the G protein-coupled receptor GPR103 regulates feeding, behavioral arousal, and blood pressure in mice Proc Natl Acad Sci USA 103 2006 7438 7443 (Pubitemid 43727851)
19. H. Wang, H. Sun, K. Della Penna, R.J. Benz, J. Xu, and D.L. Gerhold Chronic neuropathic pain is accompanied by global changes in gene expression and shares pathobiology with neurodegenerative diseases Neuroscience 114 2002 529 546 (Pubitemid 35247642)
20. H.-S. Xiao, Q.-H. Huang, F.-X. Zhang, L. Bao, Y.-J. Lu, and C. Guo Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain Proc Natl Acad Sci USA 99 2002 8360 8365 (Pubitemid 34651057)
21. T.L. Yaksh, and T.A. Rudy Chronic catheterization of the spinal subarachnoid space Physiol Behav 17 1976 1031 1036 (Pubitemid 8063691)
22. T. Yamamoto, R. Miyazaki, and Y. Yamada Intracerebroventricular administration of 26RFa produces an analgesic effect in the rat formalin test Peptides 30 2009 1683 1688
23. T. Yamamoto, T. Wada, and R. Miyazaki Analgesic Effects of intrathecally administered 26RFa, an intrinsic agonist for GPR103, on formalin test and carrageenan test in rats Neuroscience 157 2008 214 222
24. T. Yamamoto, and T.L. Yaksh Comparison of the antinociceptive effects of pre- and post-treatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat Anesthesiology 77 1992 757 763
25. T. Yamamoto, and T.L. Yaksh Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists Pain 49 1992 121 128
26. J.H. Zar Biostatistical analysis Second ed. 1984 Prentice-Hall Inc. Englewood Cliffs, NJ p. 61-78
27. J.C. do Rego, J. Leprince, N. Chartrel, H. Vaudry, and J. Costentin Behavioral effects of 26RFamide and related peptides Peptides 27 2006 2715 2721 (Pubitemid 44739952)